| abstract |
The present invention is in the field of Intelligent Drug Delivery. Targeted medicines have been developed thereto, using a Targeted Mediated Drug Delivery—technology. This technology leads drugs selectively and specifically into diseased cells/organs, in contrast to “dumping” drugs into the body. This technology is found to substantially increase the efficacy of disease treatment and reduce side—effects while much smaller amounts of drug(s) are required. In addition, a novel innovative approach is used that can be applied in the treatment of e.g. cancers, auto—immune diseases, viral diseases, transplantation, and diseases associated with inflammation. |